Cautious Optimism for Deal Making. The general consensus is that we will likely see an increase in M&A and capital market transactions in the life sciences sector in 2025....more
1/22/2025
/ Acquisition Agreements ,
Artificial Intelligence ,
Biotechnology ,
Capital Markets ,
Data Protection ,
Healthcare ,
Investment ,
Life Sciences ,
Merger Agreements ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Telehealth